Unravelling Cancer Mechanism and Developing Novel Therapeutics: An Urgent Need to Treat Cancer (2nd Edition)

Dear Colleagues,

In recent decades, concerns regarding cancer have grown rapidly. Many cancer screening programs are being implemented in high-and middle-income countries to reduce the incidence and mortality of cancer. However, the yearly rise in cases is disappointing considering the extensive use of various therapeutic approaches. Emerging evidence suggests that drug resistance and relapse also represent significant issues during treatment. Therefore, no single breakthrough can cure cancer; however, accumulating knowledge regarding the complex mechanisms implicated in the pathogenesis of cancer could reduce the associated mortality rate. Thus, understanding signaling pathways and developing novel targeted techniques, including molecular, biochemical, immunological, and nanotherapy, may provide clinicians searching for new targets for treatment with hope.

To address these challenges, this Special Issue aims to present novel targeted therapies and their underlying mechanism. The scope of this Special Issue therefore includes, but is not limited to, the following topics: natural compound combination therapy, chemotherapy, immunotherapy, and nanotherapy. We welcome you to submit original research and review articles that address recent advances in this field.

Dr. Rajesh Singh
Dr. Santosh Kumar Singh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.